ConductScience.org, home

Paper7862887

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

Nomikos GG and 4 others. Psychopharmacology (Berl), 1994. Cited by 120 papers, by iCite.

Cite this record

ConductScience Library. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Papers, record 7862887. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7862887

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
120
iCite
Relative citation ratio, by iCite
4.6
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nomikos GGG G
2Iurlo MM
3Andersson JLJ L
4Kimura KK
5Svensson THT H

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
DopamineMajor topic
PiperazinesMajor topic
Prefrontal CortexMajor topic
Serotonin AntagonistsMajor topic
Animals
Clozapine
Male
Microdialysis
Neostriatum
Nucleus Accumbens
Rats
Rats, Wistar
Ritanserin
Synaptic Transmission

Source PubMed

Download CSV of topics

References86

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12710415Differences in dopamine release and metabolism in rat striatal subregions following acute clozapine using in vivo microdialysis.Neurosci Lett1989https://conductscience.org/library/papers/2710415PubMed
22481562Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.Brain Res1989https://conductscience.org/library/papers/2481562PubMed
32852047Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.Brain Res1988https://conductscience.org/library/papers/2852047PubMed
42304894Amperozide and emotional behaviour.Pharmacol Toxicol1990https://conductscience.org/library/papers/2304894PubMed
51381923Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum.Neuropsychopharmacology1992https://conductscience.org/library/papers/1381923PubMed
61968250Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.Pharmacol Toxicol1990https://conductscience.org/library/papers/1968250PubMed
76085051Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.Eur J Pharmacol1984https://conductscience.org/library/papers/6085051PubMed
81358122Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.J Neural Transm Gen Sect1992https://conductscience.org/library/papers/1358122PubMed
91924636Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.Psychopharmacology (Berl)1991https://conductscience.org/library/papers/1924636PubMed
101674882Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.Schizophr Res1991https://conductscience.org/library/papers/1674882PubMed
111402896Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin.J Neurochem1992https://conductscience.org/library/papers/1402896PubMed
127901810Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo.Neurosci Lett1993https://conductscience.org/library/papers/7901810PubMed
137248783Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat.Brain Res1981https://conductscience.org/library/papers/7248783PubMed
14769027An example of European multicenter trials: multispectral analysis of clozapine.Psychopharmacol Bull1976https://conductscience.org/library/papers/769027PubMed
151358127General pharmacology of clozapine.Br J Psychiatry Suppl1992https://conductscience.org/library/papers/1358127PubMed
163606332Implications of normal brain development for the pathogenesis of schizophrenia.Arch Gen Psychiatry1987https://conductscience.org/library/papers/3606332PubMed
171975644Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.Nature1990https://conductscience.org/library/papers/1975644PubMed
182514690Locomotor effects of amperozide. Antagonism of amphetamine-induced locomotor stimulation.Arzneimittelforschung1989https://conductscience.org/library/papers/2514690PubMed
192304893Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo.Pharmacol Toxicol1990https://conductscience.org/library/papers/2304893PubMed
201388121Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.Eur J Pharmacol1992https://conductscience.org/library/papers/1388121PubMed

See all 86 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.

PMIDTitleJournalYearIn PapersSource
33432392Differential effects of d- and l-enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs.Psychopharmacology (Berl)2021https://conductscience.org/library/papers/33432392PubMed
25345736A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics.Psychopharmacology (Berl)2015https://conductscience.org/library/papers/25345736PubMed
20627663
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
Eur Neuropsychopharmacol2010https://conductscience.org/library/papers/20627663PubMed
20557570Role of serotonin in central dopamine dysfunction.CNS Neurosci Ther2010https://conductscience.org/library/papers/20557570PubMed
20463659Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.Neuropsychopharmacology2010https://conductscience.org/library/papers/20463659PubMed
19578925Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.J Neural Transm (Vienna)2009https://conductscience.org/library/papers/19578925PubMed
19198810Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.Psychopharmacology (Berl)2009https://conductscience.org/library/papers/19198810PubMed
18615131On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?Curr Neuropharmacol2006https://conductscience.org/library/papers/18615131PubMed
18568117Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.Neuropsychiatr Dis Treat2005https://conductscience.org/library/papers/18568117PubMed
18568103Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.Neuropsychiatr Dis Treat2005https://conductscience.org/library/papers/18568103PubMed
17940749Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.Psychopharmacology (Berl)2008https://conductscience.org/library/papers/17940749PubMed
17287939Medial prefrontal cortex infusion of alpha-flupenthixol attenuates systemic d-amphetamine-induced disruption of conditional discrimination performance in rats.Psychopharmacology (Berl)2007https://conductscience.org/library/papers/17287939PubMed
16284783Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.Naunyn Schmiedebergs Arch Pharmacol2005https://conductscience.org/library/papers/16284783PubMed
16010540The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values.Psychopharmacology (Berl)2005https://conductscience.org/library/papers/16010540PubMed
12598408The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.Br J Pharmacol2003https://conductscience.org/library/papers/12598408PubMed
8935802Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8935802PubMed
8935801Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8935801PubMed
8935797Mechanisms of action of atypical antipsychotic drugs: a critical analysis.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8935797PubMed
8912395Risperidone: a novel antipsychotic with many "atypical" properties?Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8912395PubMed
8741935Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8741935PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7862887

GET https://conductscience.org/api/papers/v1/7862887/references?page=2